Onyx Healthcare Bilan de santé

Santé financière contrôle des critères 5/6

Onyx Healthcare possède un total de capitaux propres de NT$1.5B et une dette totale de NT$216.6M, ce qui porte son ratio d'endettement à 14.6%. Son actif total et son passif total sont NT$2.1B et de NT$609.0M. L'EBIT de Onyx Healthcare est NT$121.2M ce qui fait que son ratio de couverture des intérêts -36.9. Elle dispose de liquidités et de placements à court terme de NT$284.5M.

Informations clés

14.6%

Ratio d'endettement

NT$216.62m

Dette

Ratio de couverture des intérêts	-36.9x
Argent liquide	NT$284.54m
Fonds propres	NT$1.49b
Total du passif	NT$608.96m
Total des actifs	NT$2.09b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Onyx Healthcare Inc.'s (GTSM:6569) Stock Been Rising: Are Strong Financials Guiding The Market?

Feb 05

Should You Or Shouldn't You: A Dividend Analysis on Onyx Healthcare Inc. (GTSM:6569)

Jan 14

Will Onyx Healthcare (GTSM:6569) Multiply In Value Going Forward?

Dec 23

Did You Miss Onyx Healthcare's (GTSM:6569) 14% Share Price Gain?

Dec 02

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 6569 ( NT$823.0M ) dépassent ses passifs à court terme ( NT$394.6M ).

Passif à long terme: Les actifs à court terme de 6569 ( NT$823.0M ) dépassent ses passifs à long terme ( NT$214.4M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 6569 dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de 6569 est passé de 0% à 14.6% au cours des 5 dernières années.

Couverture de la dette: La dette de 6569 est bien couverte par le flux de trésorerie opérationnel ( 52.8% ).

Couverture des intérêts: 6569 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.

Onyx Healthcare Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

Third quarter 2024 earnings released: EPS: NT$0.69 (vs NT$1.70 in 3Q 2023)

Onyx Healthcare Inc. to Report Q3, 2024 Results on Nov 06, 2024

Second quarter 2024 earnings released: EPS: NT$1.15 (vs NT$1.77 in 2Q 2023)

Investor sentiment deteriorates as stock falls 17%

Onyx Healthcare Inc. to Report Q2, 2024 Results on Aug 05, 2024

Upcoming dividend of NT$5.00 per share

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

First quarter 2024 earnings released: EPS: NT$1.52 (vs NT$1.69 in 1Q 2023)

Onyx Healthcare Inc. to Report Q1, 2024 Results on May 08, 2024

Onyx Healthcare Inc. to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: EPS: NT$7.65 (vs NT$6.24 in FY 2022)

Investor sentiment improves as stock rises 16%

Onyx Healthcare Inc., Annual General Meeting, May 27, 2024

Now 22% undervalued after recent price drop

Onyx Healthcare Inc. Announces Executive Changes

Onyx Healthcare Inc. Announces Executive Changes

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 18%

Second quarter 2023 earnings released: EPS: NT$2.03 (vs NT$0.96 in 2Q 2022)

Investor sentiment deteriorates as stock falls 17%

New major risk - Share price stability

Investor sentiment improves as stock rises 26%

Upcoming dividend of NT$5.00 per share at 3.6% yield

New minor risk - Share price stability

Investor sentiment improves as stock rises 21%

Full year 2022 earnings released: EPS: NT$6.24 (vs NT$4.22 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: NT$1.61 (vs NT$0.55 in 3Q 2021)

Second quarter 2022 earnings released: EPS: NT$0.96 (vs NT$0.63 in 2Q 2021)

Upcoming dividend of NT$4.00 per share

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Onyx Healthcare Inc., Annual General Meeting, May 31, 2022

Third quarter 2021 earnings released: EPS NT$0.55 (vs NT$1.24 in 3Q 2020)

Upcoming dividend of NT$5.50 per share

Second quarter 2021 earnings released: EPS NT$0.70 (vs NT$2.10 in 2Q 2020)

Director Yung-Shun Chuang has joined 7th company board

First quarter 2021 earnings released: EPS NT$0.63 (vs NT$0.10 in 1Q 2020)

Here's How We Evaluate Onyx Healthcare Inc.'s (GTSM:6569) Dividend

Returns On Capital At Onyx Healthcare (GTSM:6569) Paint A Concerning Picture

Full year 2020 earnings released: EPS NT$6.07 (vs NT$8.70 in FY 2019)

Shareholders Of Onyx Healthcare (GTSM:6569) Must Be Happy With Their 46% Return

Onyx Healthcare Inc., Annual General Meeting, May 25, 2021

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS NT$6.07 (vs NT$8.70 in FY 2019)

New 90-day high: NT$142

Onyx Healthcare Inc.'s (GTSM:6569) Stock Been Rising: Are Strong Financials Guiding The Market?

Should You Or Shouldn't You: A Dividend Analysis on Onyx Healthcare Inc. (GTSM:6569)

Will Onyx Healthcare (GTSM:6569) Multiply In Value Going Forward?

Did You Miss Onyx Healthcare's (GTSM:6569) 14% Share Price Gain?

Third quarter 2020 earnings released: EPS NT$1.37

New 90-day low: NT$120

New 90-day low: NT$120

New 90-day low: NT$133

First half earnings released

New 90-day high - NT$182

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines